611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Concussion May Increase Multiple Sclerosis RiskDiabetes Insipidus Can Occur After Stopping VasopressinHealth Tip: Identifying Chicken PoxHealth Tip: Do You Have Athlete's Foot?Coming Soon: Glaucoma Self-Care, From Home?Dirty Air Might Harm Your KidneysAddictive Opioids Common for People on DialysisLady Gaga's Fibromyalgia Puts Illness in the SpotlightHigh Rate of Anemia Seen After Weight-Loss SurgeryHighest Adverse Effect Rates for Three Drugs in Parkinson'sThyroid Surgery for Benign Goiters Ups Quality of LifeSteroid Injection Betters Hand Function With Carpal TunnelSound the Mosquito Alarm, Across the USAAsthma Drug Tied to Nightmares, DepressionCould Pests, Dust Lower Kids' Odds for Asthma?Health Tip: Prevent Carbon Monoxide PoisoningInflammatory Bowel Disease May Raise Cancer Risk in KidsUltrasound Echo Intensity Is Potential Frailty BiomarkerDrone Sets New Record for Transporting Blood SamplesGeneral, Central Obesity Linked to Specific Breast Cancer RiskProton Pump Inhibitors Overused WorldwideWeight-Loss Surgery May Leave Some AnemicHealth Tip: Four Common Types Of AcneOne-Quarter of Lupus Patients Have Metabolic SyndromeKids' Colds Linked to Asthma, Lung Problems LaterMetabolomic Profiles Differ With Macular DegenerationExtended Thromboprophylaxis Safe, Effective After Liver SurgeryExercise May Stem Kidney Damage in Lupus PatientsMinorities Exposed to Dirtier Air, U.S. Study FindsDoctors Eye the Danger From 'Nerf' GunsHealth Tip: Preventing Food Allergies While Dining OutIt's a Food Allergy! Where's the School Nurse?Lower Mortality Risk Seen With Statin Use in Older MenSleep Quality, Duration Linked to CKD ProgressionSelena Gomez's Kidney Transplant Puts Lupus Center StageVision Problems Common in Babies Infected With ZikaSmoking, Poor Diet Lead Global Death CausesWhich Single Behavior Best Prevents High Blood Pressure?Traces of Tattoo May Reach the Lymph NodesVitamin D Deficiency Tied to Neuropathic Pain'Upside' to Diabetes Really Isn'tSemen Harbors Wide Range of VirusesHeath Tip: Contact Lenses Aren't Risk-FreeDiabetes Threatens Kidneys, Vision of Millions of AmericansNew Guideline Aims to Help Doctors Diagnose Head, Neck Masses'Microbiomes' May Hold Key to Kids' Ear InfectionsWarfarin, Rivaroxaban Similarly Safe, EffectiveHealth Tip: Leading Causes of Food PoisoningER Visits for These 3 Health Woes Don't Have to Happen'Modest at Best' Discriminatory Ability for CBC Test in Infants
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

ACP: Recommendations Updated for Low Bone Density Treatment


HealthDay News
Updated: May 12th 2017

new article illustration

FRIDAY, May 12, 2017 (HealthDay News) -- In a clinical practice guideline update published online May 9 in the Annals of Internal Medicine, recommendations are presented for the treatment of low bone density and osteoporosis to prevent fractures.

Amir Qaseem, M.D., Ph.D., from the American College of Physicians in Philadelphia, and colleagues conducted a systematic review of the literature to update the 2008 American College of Physicians (ACP) recommendations on treatment of low bone density and osteoporosis to prevent fractures. They focused on the comparative benefits and risks of short- and long-term pharmacologic treatments for low bone density.

The authors developed six recommendations for the target patient population of men and women with low bone density and osteoporosis. For women with known osteoporosis, the ACP recommends that clinicians offer alendronate, risedronate, zoledronic acid, or denosumab to reduce the risk for hip and vertebral fractures. Osteoporotic women should be treated with pharmacologic therapy for five years; during the treatment period, the ACP recommends against bone density monitoring. For men who have clinically recognized osteoporosis, clinicians should offer pharmacologic treatment with bisphosphonates to reduce vertebral fracture risk.

In addition, for women with osteoporosis, the ACP recommends against menopausal estrogen therapy or menopausal estrogen plus progesterone therapy or raloxifene. For osteopenic women aged 65 years or older, clinicians should made the decision to provide treatment after discussion of patient preferences; fracture risk profile; and benefits, harms, and costs of medications.

Abstract/Full Text
Editorial (subscription or payment may be required)